Company profile: Bionova Scientific
1.1 - Company Overview
Company description
- Provider of biologics development and manufacturing services, specializing in cell line development for new biological entities and biosimilars, upstream and downstream process development, analytical sciences, and formulation. Offers GMP manufacturing with single-use bioreactors, scale-up and tech transfer support, expertise with complex proteins and antibody drug conjugates, and regulatory compliance without licensing fees.
Products and services
- Cell Line Development: Bionova specializes in developing cell lines for complex proteins, including NBEs and biosimilars, delivering optimization and regulatory compliance without licensing fees through regulatory-compliant workflows
- GMP Manufacturing of Biologics: Bionova produces commercial-ready GMP biologics clinical supply using single-use bioreactors and flexible processes for global supply, delivering GMP-compliant manufacturing
- Upstream Process Development: Bionova architects comprehensive upstream process development, executing clone and media screening, process optimization, and perfusion process development for complex proteins within perfusion-based programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bionova Scientific
ABL
HQ: United States
Website
- Description: Provider of biotechnology contract research, development, and manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABL company profile →
Caidya
HQ: United States
Website
- Description: Provider of clinical research services with personalized solutions across therapeutic areas, supported by a proprietary technology platform that integrates data from different systems to create a near real-time view of clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caidya company profile →
Ritedose
HQ: United States
Website
- Description: Provider of pharmaceutical products and services focused on the respiratory market. A leader in blow-fill-seal (BFS) manufacturing of small-fill unit dose sterile and non-sterile liquids for inhalation and ophthalmic use. Offers 503B outsourcing with pre-filled, ready-to-use syringes for hospitals and generic inhalation solutions including cromolyn sodium, albuterol sulfate, and arformoterol tartrate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ritedose company profile →
Amatsigroup
HQ: France
Website
- Description: Provider of GLP- and GMP-compliant CRO/CMO services for human and veterinary pharmaceutical product development, leveraging the expertise of renowned CROs/CMOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amatsigroup company profile →
AGC Biologics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AGC Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bionova Scientific
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bionova Scientific
2.2 - Growth funds investing in similar companies to Bionova Scientific
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bionova Scientific
4.2 - Public trading comparable groups for Bionova Scientific
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →